Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)
收藏DataCite Commons2026-04-09 更新2024-07-13 收录
下载链接：
https://gen3.biodatacatalyst.nhlbi.nih.gov/discovery/phs002752.v1.p1.c1/
下载链接
链接失效反馈官方服务：
资源简介：
The Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) is a multicenter, randomized, single blind, two-arm, placebo controlled Phase III trial with blinded outcome assessments to establish the safety and efficacy of single dose of convalescent plasma for preventing the progression from mild to severe COVID-19 illness.
提供机构：
NHLBI BioData Catalyst
创建时间：
2024-05-31
